Heidi M. Jolson

460 total citations
10 papers, 190 citations indexed

About

Heidi M. Jolson is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Heidi M. Jolson has authored 10 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Heidi M. Jolson's work include Cardiac electrophysiology and arrhythmias (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Pharmacovigilance and Adverse Drug Reactions (1 paper). Heidi M. Jolson is often cited by papers focused on Cardiac electrophysiology and arrhythmias (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Pharmacovigilance and Adverse Drug Reactions (1 paper). Heidi M. Jolson collaborates with scholars based in United States, Thailand and Oman. Heidi M. Jolson's co-authors include B. Burt Gerstman, Richard Platt, Pyone Cho, Mark Bauer, James M. Livingston, Thaddeus H. Grasela, Dianne L. Kennedy, Cynthia A. Walawander, Gary L. Simpson and Mark J. Sotir and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Clinical Infectious Diseases and Journal of Clinical Epidemiology.

In The Last Decade

Heidi M. Jolson

9 papers receiving 171 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidi M. Jolson United States 7 55 38 37 22 22 10 190
Maria Giner‐Soriano Spain 11 100 1.8× 31 0.8× 26 0.7× 13 0.6× 50 323
Andrés Gaviria‐Mendoza Colombia 10 44 0.8× 43 1.1× 17 0.5× 13 0.6× 77 282
Maja Laursen Denmark 7 49 0.9× 12 0.3× 18 0.5× 10 0.5× 9 274
Tracy Sandritter United States 11 17 0.3× 27 0.7× 24 0.6× 18 0.8× 27 312
Nadir Yalçın Türkiye 10 16 0.3× 33 0.9× 15 0.4× 11 0.5× 47 237
Ainhoa Gómez-Lumbreras United States 10 36 0.7× 8 0.2× 40 1.1× 11 0.5× 47 243
Nathan Pauly United States 9 23 0.4× 4 0.1× 14 0.4× 10 0.5× 7 0.3× 22 330
Ann M. Philbrick United States 10 18 0.3× 13 0.3× 30 0.8× 6 0.3× 30 218
Einat Gorelik Israel 7 36 0.7× 34 0.9× 49 1.3× 18 0.8× 8 282
Smita Sontakke India 9 16 0.3× 21 0.6× 49 1.3× 4 0.2× 28 304

Countries citing papers authored by Heidi M. Jolson

Since Specialization
Citations

This map shows the geographic impact of Heidi M. Jolson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi M. Jolson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi M. Jolson more than expected).

Fields of papers citing papers by Heidi M. Jolson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi M. Jolson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi M. Jolson. The network helps show where Heidi M. Jolson may publish in the future.

Co-authorship network of co-authors of Heidi M. Jolson

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi M. Jolson. A scholar is included among the top collaborators of Heidi M. Jolson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi M. Jolson. Heidi M. Jolson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Chapman, Louisa E., B. A. Ellis, Frederick Koster, et al.. (2002). Discriminators between Hantavirus-Infected and -Uninfected Persons Enrolled in a Trial of Intravenous Ribavirin for Presumptive Hantavirus Pulmonary Syndrome. Clinical Infectious Diseases. 34(3). 293–304. 35 indexed citations
3.
Spring, Susan B., E L Tierney, & Heidi M. Jolson. (1997). Development of Outcome Measures for Therapeutic Trials of Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome. 3(3). 69–95. 2 indexed citations
4.
Gerstman, B. Burt, Heidi M. Jolson, Mark Bauer, et al.. (1996). The incidence of depression in new users of beta-blockers and selected antihypertensives. Journal of Clinical Epidemiology. 49(7). 809–815. 55 indexed citations
5.
Grasela, Thaddeus H., Cynthia A. Walawander, Dianne L. Kennedy, & Heidi M. Jolson. (1993). Capability of Hospital Computer Systems in Performing Drug-use Evaluations and Adverse Drug Event Monitoring. American Journal of Health-System Pharmacy. 50(9). 1889–1895. 21 indexed citations
6.
Jolson, Heidi M., Laura Bosco, B. Burt Gerstman, et al.. (1992). Clustering of Adverse Drug Events: Analysis of Risk Factors for Cerebellar Toxicity With High-Dose Cytarabine. JNCI Journal of the National Cancer Institute. 84(7). 500–505. 13 indexed citations
7.
Jolson, Heidi M., et al.. (1992). Propafenone Associated Agranulocytosis. Pacing and Clinical Electrophysiology. 15(4). 387–390. 6 indexed citations
8.
Jolson, Heidi M.. (1992). Do Fluoroquinolones Alter the Effects of Warfarin Therapy?-Reply. Archives of Internal Medicine. 152(7). 1534–1534. 1 indexed citations
9.
Jolson, Heidi M.. (1991). Adverse Reaction Reporting of Interaction Between Warfarin and Fluoroquinolones. Archives of Internal Medicine. 151(5). 1003–1003. 50 indexed citations
10.
Gillis, Richard A., Heidi M. Jolson, Harold Thibodeaux, & Barrie Levitt. (1975). Antagonism of deslanoside-induced cardiotoxicity by combined nicotinic and muscarinic blockade of autonomic ganglia.. Journal of Pharmacology and Experimental Therapeutics. 195(1). 126–132. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Giner‐Soriano Breakdown of academic impact, for papers by Andrés Gaviria‐Mendoza Breakdown of academic impact, for papers by Maja Laursen Breakdown of academic impact, for papers by Tracy Sandritter Breakdown of academic impact, for papers by Nadir Yalçın Breakdown of academic impact, for papers by Ainhoa Gómez-Lumbreras Breakdown of academic impact, for papers by Nathan Pauly Breakdown of academic impact, for papers by Ann M. Philbrick Breakdown of academic impact, for papers by Einat Gorelik Breakdown of academic impact, for papers by Smita Sontakke
Rankless by CCL
2026